Published in Alcohol Clin Exp Res on November 01, 2003
Continuing care research: what we have learned and where we are going. J Subst Abuse Treat (2009) 2.77
Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review. Clin Gastroenterol Hepatol (2015) 2.04
The case for chronic disease management for addiction. J Addict Med (2008) 1.36
Readiness to change in primary care patients who screened positive for alcohol misuse. Ann Fam Med (2006) 1.17
Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation. Alcohol Clin Exp Res (2009) 1.12
Treatment of alcoholic liver disease. Dig Dis (2005) 1.10
S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial. Alcohol Clin Exp Res (2011) 0.94
Treating alcoholism as a chronic disease: approaches to long-term continuing care. Alcohol Res Health (2011) 0.94
Experience of a single center with congenital hepatic fibrosis: a review of the literature. World J Gastroenterol (2010) 0.93
Gaps in clinical prevention and treatment for alcohol use disorders: costs, consequences, and strategies. Alcohol Res (2013) 0.79
Care for hospitalized patients with unhealthy alcohol use: a narrative review. Addict Sci Clin Pract (2013) 0.76
Essential phospholipids in fatty liver: a scientific update. Clin Exp Gastroenterol (2016) 0.75
Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial. Addict Sci Clin Pract (2017) 0.75
What can general medical providers do for hospitalized patients with alcohol dependence after discharge? J Gen Intern Med (2010) 0.75
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med (2006) 10.97
Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med (2005) 5.88
An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med (2006) 5.02
Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice. Ann Intern Med (2005) 4.38
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology (2007) 4.09
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol (2003) 4.05
Five-year colon surveillance after screening colonoscopy. Gastroenterology (2007) 3.74
Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc (2002) 3.16
Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA (2003) 2.68
Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol (2009) 2.59
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell (2003) 2.16
Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology (2010) 1.95
Current management of portal hypertension. J Hepatol (2003) 1.81
First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol (2003) 1.73
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology (2009) 1.59
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. J Hepatol (2007) 1.55
Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol (2002) 1.31
Ethanol-induced oxidative stress precedes mitochondrially mediated apoptotic death of cultured fetal cortical neurons. J Neurosci Res (2003) 1.29
Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol (2006) 1.18
Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival. Gastroenterology (2005) 1.15
II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res (2003) 1.14
Astrocytes protect neurons from ethanol-induced oxidative stress and apoptotic death. J Neurosci Res (2005) 1.12
Expert pediatric opinion on the Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant (2006) 1.00
Glutathione content as a potential mediator of the vulnerability of cultured fetal cortical neurons to ethanol-induced apoptosis. J Neurosci Res (2008) 1.00
Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area. Am J Gastroenterol (2002) 0.97
Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol (2010) 0.96
Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol Clin Exp Res (2008) 0.96
Astrocyte control of fetal cortical neuron glutathione homeostasis: up-regulation by ethanol. J Neurochem (2006) 0.95
Ethanol-mediated DNA damage and PARP-1 apoptotic responses in cultured fetal cortical neurons. Alcohol Clin Exp Res (2008) 0.92
4-hydroxynonenal detoxification by mitochondrial glutathione S-transferase is compromised by short-term ethanol consumption in rats. Alcohol Clin Exp Res (2002) 0.86
The role of vitamin E and C therapy in NASH. Am J Gastroenterol (2004) 0.81
The role of nutritional therapy in alcoholic liver disease. Alcohol Res Health (2006) 0.80
The usefulness of laboratory tests in the early assessment of severity of acute pancreatitis. Crit Rev Clin Lab Sci (2003) 0.80
Cytokeratin 7 staining of hepatocytes predicts progression to more severe fibrosis in alcohol-fed baboons. J Hepatol (2003) 0.78
Insulin sensitizers in nonalcoholic steatohepatitis. Hepatology (2011) 0.76
Hepatology over the years. Hepatology (2006) 0.75
Hyperamylasemia and acidemia: is there an association? Pancreas (2004) 0.75